This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (27)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Psychiatry  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

John W. Newcomer, MD; Charles H. Hennekens, MD

JAMA. 2007;298:1794-1796.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Cardiovascular disease (CVD), including coronary heart disease (CHD), stroke, and peripheral vascular disease, is the leading cause of death in the United States and most developed Western countries, and will remain so during the 21st century.¹ In 2004, CVD was listed as the underlying cause of death in 871 517 of all 2 398 000 deaths (36.3%), or 1 of every 2.8 deaths in the United States, with CHD accounting for 52% and stroke for 17%.² During the past several decades, CVD mortality has markedly declined in the United States, from more than 50% to approximately 36% as the underlying cause of death. Recent data suggest that the decline is largely due to improved diagnosis and treatment rather than to major successes in primary prevention. In contrast, patients with severe mental illnesses, such as schizophrenia, bipolar disorder, and depression that together affect 5% to 10% . . . [Full Text of this Article]

Author Affiliations: Departments of Psychiatry, Psychology, and Medicine, and the Center for Clinical Studies, Washington University School of Medicine, St Louis, Missouri (Dr Newcomer); and the Charles E. Schmidt College of Biomedical Science, Department of Clinical Science and Medical Education and Center of Excellence, Florida Atlantic University, Boca Raton, Departments of Medicine and Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, and Department of Preventive Medicine, NOVA Southeastern University, Fort Lauderdale, Florida (Dr Hennekens).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psychiatric and General Medical Conditions Comorbid With Schizophrenia in the National Hospital Discharge Survey
Weber et al.
Psychiatr. Serv. 2009;60:1059-1067.
ABSTRACT | FULL TEXT  

Somatic Hospital Contacts, Invasive Cardiac Procedures, and Mortality From Heart Disease in Patients With Severe Mental Disorder
Laursen et al.
Arch Gen Psychiatry 2009;66:713-720.
ABSTRACT | FULL TEXT  

Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes
Morrato et al.
Diabetes Care 2009;32:1037-1042.
ABSTRACT | FULL TEXT  

Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents
Haupt et al.
Am. J. Psychiatry 2009;166:345-353.
ABSTRACT | FULL TEXT  

A 51-Year-Old Woman With Bipolar Disorder Who Wants to Quit Smoking
Schroeder
JAMA 2009;301:522-531.
ABSTRACT | FULL TEXT  

Psychiatric Hospital Admissions, Behavioral Risk Factors, and All-Cause Mortality: The Scottish Health Survey
Hamer et al.
Arch Intern Med 2008;168:2474-2479.
ABSTRACT | FULL TEXT  

Whose line is it anyway?
van Hecke
Psychiatr. Bull. 2008;32:198-198.
FULL TEXT  

Major psychiatric disorders increase risk of mortality
Craig
Evid. Based Ment. Health 2008;11:9-9.
FULL TEXT